Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2018 Jun 15;17(9):1859–1870. doi: 10.1158/1535-7163.MCT-17-1176

Figure 6. In vivo anticancer activity of bromocriptine and its combination with docetaxel in C4-2-Luc intratibial xenografts.

Figure 6

(A) Left: serum PSA levels of tumor-bearing mice under different treatments; Right: Two-way ANOVA of pairwise comparison of the PSA values between any two treatment groups. p< 0.05 was considered as statistically significant. (B) Upper panel: X-ray radiography of tumor-bearing tibias under different treatments. Yellow arrow: osteoblastic lesion; pink arrow: osteolytic lesion. Lower panel: H&E staining of bone tumor tissues. Bar scale: 200 μm.